Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
F (ADMET) | = 10 % | Oral bioavailability in rat | ChEMBL. | 18207397 |
IC50 (binding) | = 0.012 uM | Inhibition of PDE4 (unknown origin) expressed in SF9 cells | ChEMBL. | 18207397 |
IC50 (functional) | = 0.56 uM | Inhibition of LPS-stimulated TNFalpha release in human whole blood | ChEMBL. | 18207397 |
IC50 (functional) | = 0.56 uM | Inhibition of LPS-stimulated TNFalpha release in human whole blood | ChEMBL. | 18207397 |
t1/2 (ADMET) | = 1.7 hr | Half life in rat | ChEMBL. | 18207397 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 18207397 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.